ICU Medical, Inc. [ICUI] stock is trading at $148.07, down -3.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The ICUI shares have gain 23.72% over the last week, with a monthly amount glided 17.53%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Raymond James upgraded its rating to Outperform on June 17, 2024, and kept the price target unchanged to $135. On November 08, 2022, downgrade downgraded it’s rating to Mkt Perform. CJS Securities upgraded its rating to a Market Outperform. KeyBanc Capital Markets upgraded its rating to a Overweight but $206 remained the price target by the analyst firm on March 18, 2020. Raymond James downgraded its rating to Outperform for this stock on August 08, 2019. In a note dated October 17, 2017, KeyBanc Capital Mkts initiated an Sector Weight rating.
ICU Medical, Inc. [ICUI] stock has fluctuated between $78.28 and $153.55 over the past year. Currently, Wall Street analysts expect the stock to reach $135 within the next 12 months. ICU Medical, Inc. [NASDAQ: ICUI] shares were valued at $148.07 at the most recent close of the market. An investor can expect a potential drop of -8.83% based on the average ICUI price forecast.
Analyzing the ICUI fundamentals
ICU Medical, Inc. [NASDAQ:ICUI] reported sales of 2.30B for the trailing twelve months, which represents a growth of 8.56%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 145.92 points at the first support level, and at 143.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 152.02, and for the 2nd resistance point, it is at 155.96.
Ratios To Look Out For
For context, ICU Medical, Inc.’s Current Ratio is 2.40. On the other hand, the Quick Ratio is 1.07, and the Cash Ratio is 0.59. Considering the valuation of this stock, the price to sales ratio is 1.57, the price to book ratio is 1.77.
Transactions by insiders
Recent insider trading involved VIRGINIA SANZONE, Officer, that happened on Aug 08 ’24 when 2050.0 shares were purchased. VP, General Counsel, Sanzone Virginia Ruth completed a deal on Aug 08 ’24 to sell 2050.0 shares. Meanwhile, Chief Operating Officer Voigtlander Christian B. sold 12539.0 shares on May 30 ’24.
